Search
for
Sort by
Research 841–870 of 1000+
- Retinoids in Hair Disorders
- Androgenetic alopecia
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Prevalence of Male and Female Pattern Hair Loss in Maryborough
- Treatment of female pattern hair loss with oral antiandrogens
- Fortnightly review: Male pattern androgenetic alopecia
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Epidermal Wnt/β-catenin signaling regulates adipocyte differentiation via secretion of adipogenic factors
- Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
- Male androgenetic alopecia
- Follicular miniaturization in female pattern hair loss: clinicopathological correlations
- Management of primary cicatricial alopecias: options for treatment
- Treatment of alopecia areata: An Australian expert consensus statement
- Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know
- Epidemiology of skin cancer in the mature patient
- There is no clear association between low serum ferritin and chronic diffuse telogen hair loss
- Gene-wide association study between the aromatase gene (<i>CYP19A1</i>) and female pattern hair loss
- Androgenetic alopecia in men and women
- Hair colouring, permanent styling and hair structure
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Permanent alopecia following chemotherapy and bone marrow transplantation
- Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study
- Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
- Finasteride for female androgenetic alopecia
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study